Hepatitis B virus infection among pregnant mothers and children after the introduction of the universal vaccination program in Central Vietnam

Author:

Miyakawa Masami,Yoshida Lay-Myint,Nguyen Hien-Anh Thi,Takahashi Kensuke,Le Tho Huu,Yasunami Michio,Ariyoshi Koya,Dang Duc-Anh,Moriuchi Hiroyuki

Abstract

AbstractA birth cohort study was conducted in Khan Hoa Province, central Vietnam between 2009 and 2012 to determine the seroprevalence of hepatitis B virus (HBV) in pregnant women and their children, and associated risk factors. We enrolled 1987 pregnant women with their babies at the birth phase, and 12.6% (95% confidence interval [CI]: 11.1–14.0) of mothers were hepatitis B surface antigen (HBsAg)+. At 2-year follow-up phase, 1339 (67.4%) children were enrolled of whom 76.6% completed hepatitis B vaccines (HepB) and 1.9% (95% CI: 1.2–2.7) were HBsAg+. When mothers were hepatitis B e antigen (HBeAg)+, 28.3% of children have got infected even with complete HepB. HBV infection in mothers, hepatitis B surface antibody (anti-HBs antibody) below the seroprotective level in children, and mothers with pre-pregnancy low body mass index were associated with HBV infection in children. Meanwhile, HBV infection in children, older maternal age, no or incomplete doses of HepB, and boys were associated with anti-HBs antibody below the seroprotective level in children. Our birth cohort study determined a low rate of congenital HBV infection and associated risk factors in Vietnam, however further studies are needed to advance prevention including anti-viral therapy in pregnant women at high risk.

Funder

Japan Agency for Medical Research and Development

Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference42 articles.

1. WHO | Hepatitis B position paper. World Health Organization. http://www.who.int/immunization/policy/position_papers/hepatitis_b/en/ (2017).

2. WHO | Key facts _ Hepatitis B. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (2020).

3. WHO | Global hepatitis report, 2017. World Health Organization. http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ (2017).

4. Van Damme, P. Long-term protection after Hepatitis B vaccine. J. Infect. Dis. 214, 1–3 (2016).

5. Leuridan, E. & Van Damme, P. Hepatitis B and the need for a booster dose. Clin. Infect. Dis. 53, 68–75 (2011).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3